List of works by Paolo Grassi

Adjuvant treatment for renal cell carcinoma: in the long run will we get the same answers?

scientific article published on 07 July 2016

Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer

scientific article published on 01 May 2007

Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice

scientific article published on December 2016

Cabozantinib in the treatment of advanced renal cell carcinoma: design, development, and potential place in the therapy

scientific article

Chronomodulated Capecitabine and Adjuvant Radiation in Intermediate-risk to High-risk Rectal Cancer

scientific article published on 01 December 2014

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

scientific article

Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective From a Referral Center

scientific article

Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma

scientific article published on June 2015

Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?

scientific article published on 11 August 2017

Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?

scientific article published on 09 January 2017

Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data

scientific article

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

scientific article published on 11 January 2017

Evolving treatment landscape in metastatic renal cell carcinoma: where are we now?

scientific article published on 28 January 2016

Immunotherapy advances in uro-genital malignancies

scientific article

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience

scientific article

Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents.

scientific article published on 17 February 2017

Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity

scientific article

Predicting Molecular Models: Where Are We Going?

scientific article published on 09 October 2015

Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation

scientific article published on 16 May 2015

Prognostic role of pancreatic metastases from renal cell carcinoma: results from an Italian center

scientific article published on 20 June 2013

Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma

scientific article published on November 2014

Response to targeted therapy in urachal adenocarcinoma

scientific article

Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors

scientific article

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors

scientific article published on 5 July 2016

Safety profile and treatment response of everolimus in different solid tumors: an observational study

scientific article published on January 2014

Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma: results from a large cohort of patients

scientific article published in May 2014

Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib

scientific article

Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience.

scientific article published on 7 January 2017

TOKIO rationale and protocol: a phase II study to evaluate the activity and safety of third-line tyrosine kinase inhibitor after 2 tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma

scientific article

Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factor

scientific article published on June 2014

Targeted treatments in advanced renal cell carcinoma: focus on axitinib.

scientific article

Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients

Treatment of collecting duct carcinoma: current status and future perspectives

scientific article

Treatment of elderly patients with metastatic renal cell carcinoma

scientific article

Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II).

scientific article published on 6 August 2010

What advances have been made in immune-therapy for renal cell carcinoma?

scientific article published on 10 February 2017

Paulina is supported by:

About Paulina

Help